Drug-Resistant Profiles and Genetic Diversity of Mycobacterium Tuberculosis Revealed by Whole-Genome Sequencing in Hinggan League of Inner Mongolia, China

被引:0
|
作者
Feng, Liping [1 ]
He, Wencong [2 ]
Song, Zexuan [3 ]
Zhao, Bing [3 ]
Teng, Chong [3 ]
Liu, Eryong [3 ]
Zhu, Hanfang [1 ]
Pei, Shaojun [4 ]
Liu, Lina [5 ]
Song, Yuanyuan [3 ]
Zheng, Yang [3 ]
Liu, Xiangyi [2 ]
Zhao, Yanlin [3 ]
Ou, Xichao [3 ]
机构
[1] Hinggan League Ctr Dis Control & Prevent, Dept Microbiol, Ulanhot 137499, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Dept Clin Lab, Beijing 100176, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Natl Key Lab Intelligent Tracking & Forecasting In, Beijing 102206, Peoples R China
[4] Peking Univ, Sch Publ Hlth, Beijing 100191, Peoples R China
[5] Hinggan League Peoples Hosp, Blood Transfus Dept, Ulanhot 137400, Peoples R China
来源
基金
国家重点研发计划;
关键词
Mycobacterium tuberculosis; drug resistance; genetic diversity; whole-genome sequencing; RIFAMPICIN RESISTANCE; RPOB MUTATIONS; TRANSMISSION;
D O I
10.2147/IDR.S466197
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Tuberculosis remains a major public health concern in China, with varying prevalence and drug resistance profiles across regions. This study explores the genetic diversity and drug-resistant profiles of MTB strains in Hinggan League, a high TB Methods: This population-based retrospective study, encompassing all culture-positive TB cases from Jun. 2021 to Jun. 2023 in Hinggan League. Drug resistant profiles and genetic diversity of MTB strains were assessed using phenotypic drug susceptibility testing and whole-genome sequencing. Risk factors associated with drug resistance were analyzed using univariate and multivariate Results: A total of 211 MTB strains were recovered successfully and included into final analysis. Lineage 2.2.1 (88.6%, 187/211) was the dominant sub-lineage, followed by lineage 4.5 (7.1%, 15/211) and lineage 4.4 (4.3%, 9/211). MTB strains exhibited the highest resistance rates to isoniazid (16.1%, 34/211), followed by rifampicin (10.0, 21/211). In addition, the MTB strains also showed relatively high rates of resistance against new and repurposed anti-TB drugs, with resistant rates of 2.4% (5/211) to delamanid and 1.9% (4/211) to bedaquiline. Overall, 25.6% (54/211) of MTB strains were DR-TB, and 14 MTB strains met the definition of MDRTB, including 7 strains of simple-MDR-TB, 5 of pre-XDR-TB, and 2 of XDR-TB. Genetic analysis revealed that the dominant mutations of isoniazid-, rifampin-, ethambutol-, levofloxacin-/moxifloxacin-, and ethionamide- resistance were katG_Ser315Thr (46.4%), rpoB_Ser450Leu (47.4%), embB_Met306Val (25.0%), gyrA_Asp94Ala (40.0%), and fabG1_c15t (42.9%), respectively. Previously treated patients (AOR = 2.015, 95% CI: 1.052-4.210) and male patients (AOR = 3.858, 95% CI: 1.416-10.511) were Conclusion: Our study offers crucial insights into the genetic diversity and drug-resistant profiles of TB strains circulating in Hinggan League. These findings are valuable for DR-TB surveillance and for guiding treatment regimens and public health interventions in the region.
引用
收藏
页码:3089 / 3100
页数:12
相关论文
共 50 条
  • [21] Whole-genome sequencing targets drug-resistant bacterial infections
    Punina, N. V.
    Makridakis, N. M.
    Remnev, M. A.
    Topunov, A. F.
    HUMAN GENOMICS, 2015, 9
  • [22] Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China
    Wei, Liqing
    Chen, Jun
    Deng, Zhen
    Zhang, Zefang
    Zhang, Zhengbin
    Duan, Qionghong
    FRONTIERS IN PUBLIC HEALTH, 2025, 13
  • [23] Genetic Diversity of Mycobacterium tuberculosis Isolates from Inner Mongolia, China
    Yu, Qin
    Su, Yunkai
    Lu, Bing
    Ma, Yan
    Zhao, Xiuqin
    Yang, Xiaomin
    Dong, Haiyan
    Liu, Yao
    Lian, Lulu
    Wan, Li
    Wu, Yimou
    Wan, Kanglin
    PLOS ONE, 2013, 8 (05):
  • [24] Analysis of Factors Influencing Multidrug-Resistant Tuberculosis and Validation of Whole-Genome Sequencing in Children with Drug-Resistant Tuberculosis
    Zhang, Ying
    Zhao, Ruiqiu
    Zhang, Zhenzhen
    Liu, Quanbo
    Zhang, Aihua
    Ren, Qiaoli
    Li, Siyuan
    Long, Xiaoru
    Xu, Hongmei
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 4375 - 4393
  • [25] Whole-Genome Sequencing and Annotation of a Drug-Resistant Extrapulmonary Clinical Isolate of Beijing Genotype Mycobacterium tuberculosis from Pune, India
    Hatolkar, Swarupa M.
    Misra, Rabindra N.
    Mahato, Rajesh
    Jadhav, Savita
    GENOME ANNOUNCEMENTS, 2018, 6 (25)
  • [26] Clinical application of whole-genome sequencing in the management of extensively drug-resistant tuberculosis: a case report
    Katale, Bugwesa Z.
    Rofael, Sylvia
    Elton, Linzy
    Mbugi, Erasto V.
    Mpagama, Stella G.
    Mtunga, Daphne
    Mafie, Maryjesca G.
    Mbelele, Peter M.
    Williams, Charlotte
    Mvungi, Happiness C.
    Williams, Rachel
    Saku, Gulinja A.
    Ruta, Joanitha A.
    Mchugh, Timothy D.
    Matee, Mecky I.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2024, 23 (01)
  • [27] Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis
    Gygli, Sebastian M.
    Keller, Peter M.
    Ballif, Marie
    Blochliger, Nicolas
    Homke, Rico
    Reinhard, Miriam
    Loiseau, Chloe
    Ritter, Claudia
    Sander, Peter
    Borrell, Sonia
    Collantes Loo, Jimena
    Avihingsanon, Anchalee
    Gnokoro, Joachim
    Yotebieng, Marcel
    Egger, Matthias
    Gagneux, Sebastien
    Bottger, Erik C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [28] Insight into the drug-resistant characteristics and genetic diversity of multidrug-resistant Mycobacterium tuberculosis in China
    Song, Zexuan
    Liu, Chunfa
    He, Wencong
    Pei, Shaojun
    Liu, Dongxin
    Cao, Xiaolong
    Wang, Yiting
    He, Ping
    Zhao, Bing
    Ou, Xichao
    Xia, Hui
    Wang, Shengfen
    Zhao, Yanlin
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [29] Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance
    Chaiyachat, Pratchakan
    Chaiprasert, Angkana
    Nonghanphithak, Ditthawat
    Smithtikarn, Saijai
    Kamolwat, Phalin
    Pungrassami, Petchawan
    Reechaipichitkul, Wipa
    Ong, Rick Twee-Hee
    Teo, Yik-Ying
    Faksri, Kiatichai
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (03)
  • [30] Analysis of Drug-Resistance Characteristics and Genetic Diversity of Multidrug-Resistant Tuberculosis Based on Whole-Genome Sequencing on the Hainan Island, China
    Wang, Jieying
    Yu, Chunchun
    Xu, Yuni
    Chen, Zhuolin
    Qiu, Wenhua
    Chen, Shaowen
    Pei, Hua
    Zhong, Yeteng
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 5783 - 5798